Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout. As 2026 began, J&J CEO Joaquin Duato said the company ...

Jason Weidman will join Teleflex as president and CEO, effective June 8, from Medtronic. He succeeds Stuart Randle, a Teleflex board member who was appointed to the roles on an interim basis in ...

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

The medical device supplier said that a threat actor accessed company systems through a social engineering attack.

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

Zimmer Biomet said Tuesday it has appointed Chintan Desai president of its Asia Pacific region, effective immediately. Desai ...

The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery ...

Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.

The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after ...